No Data
No Data
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
Leerink Partners Maintains Market Perform on Recursion Pharmaceuticals, Lowers Price Target to $6
Recursion Pharmaceuticals Analyst Ratings
Earnings Call Summary | Recursion Pharmaceuticals(RXRX.US) Q4 2024 Earnings Conference
Recursion Pharmaceuticals Q4 EPS $(0.53) Misses $(0.46) Estimate, Sales $4.55M Miss $19.04M Estimate
Recursion Pharmaceuticals GAAP EPS of -$0.53 Misses by $0.07, Revenue of $4.55M Misses by $14.49M